Concord Medical Services Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions CNY

Scroll to see more
Concord Medical Services Holdings Limited income statement - Annual data in millions CNY
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue383.96537.40472.09485.63223.01
Cost of Revenue463.12614.01624.49542.53209.93
Gross Profit-79.16-76.61-152.41-56.9013.08
Operating Expenses
Research & Development0.000.000.000.000.00
Selling, General & Administrative453.00386.38372.64401.42320.58
Operating Expenses453.00386.38372.64401.42320.58
Operating Income-532.16-462.99-525.05-458.32-307.50
Other Income/Expense
Interest Income13.9810.8310.025.898.44
Interest Expense193.20-165.67-120.3673.79-81.36
Other Income/Expense-137.42-5.57-11.35-3.026.31
Income
Income Before Tax-669.58-555.59-839.90-529.24-441.65
Income Tax Expense-17.51-24.57-70.91-6.57-37.62
Net Income-308.24-297.66-489.66-271.43-309.99
Net Income - Continuous Operations-308.24-531.02-768.99-522.670.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-345.62-344.16-401.86-351.37-236.72
EBIT-476.38-462.99-525.05-455.45-307.50
Depreciation & Amortization130.76118.83123.19104.0870.79
Earnings Per Share
Basic EPS-2117.00-68.00-112.00-188.00-153.00
Diluted EPS-2117.00-68.00-112.00-188.00-153.00
Basic Shares Outstanding0.154.374.374.374.37
Diluted Shares Outstanding0.154.374.374.374.37